Company intelligence / Profile preview

MFB Fertility

Boulder, Colorado, United Statesproovtest.com ↗

Ownership: Private
Development stage: Other

Overview

The company’s flagship product "Proov" is the first FDA-cleared at-home test to confirm successful ovulation by measuring urinary PdG. It empowers women to track their reproductive health and has been validated for home use. No clinical drug development results as it’s a diagnostic device.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Device (in-home diagnostic test)
Industry: Metabolite Diagnostics

Partnerships

None publicly disclosed; may have medical advisors and collaborations with clinics but no major pharma/biotech partnerships listed

Beyond the preview

Go deeper on MFB Fertility.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MFB Fertility.